Cipla gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Susmita Roy28 Feb 2022 1:19 PM ISTNew Delhi: Pharmaceutical major, Cipla has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Cipla gets CDSCO panel green signal to conduct Paxlovid trials in India Roshni Dhar28 Feb 2022 12:10 PM ISTIn a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 26/February/2022 Roshni Dhar26 Feb 2022 4:13 PM ISTHere are top health stories for the dayIndia fears for its children as thousands of MBBS students stuck in Ukraine Amid the growing...
Cipla gets CDSCO panel nod to conduct Indian trials of Paxlovid Dr. Divya Colin26 Feb 2022 12:06 PM ISTNew Delhi: In a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Kedar Upadhye steps down as Cipla Global CFO Ruchika Sharma6 Feb 2022 10:45 AM ISTMumbai: Cipla has recently announced that Kedar Upadhye has, on February 4, 2022, resigned from the position of Global Chief Financial Officer and...
Cipla to acquire 32.49 percent stake in solar power firm AMP Energy Green Eleven Ruchika Sharma6 Feb 2022 10:15 AM ISTNew Delhi: Drug major Cipla has recently announced that the company has signed a pact to acquire 32.49 per cent stake in AMP Energy Green Eleven to...
Cipla Independent Director Naina Lal Kidwai resigns Ruchika Sharma27 Jan 2022 10:15 AM ISTMumbai: Cipla has recently announced that Ms. Naina Lal Kidwai, Independent Director of the Company has resigned from the position of...
Health Bulletin 30/December/2021 Roshni Dhar30 Dec 2021 5:59 PM ISTHere are Top health stories of the dayNiti Aayog Releases Health Index NEET PG Impasse Continues, More Doctors Join Strike MBBS, BDS Admissions...
Cipla bags DCGI nod for COVID-19 oral antiviral, all set to launch Cipmolnu in India Ruchika Sharma28 Dec 2021 3:00 PM ISTMolnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.
Cipla bags USFDA nod for Lanreotide Injection Ruchika Sharma20 Dec 2021 12:54 PM ISTMumbai: Cipla Limited along with its subsidiary Cipla USA, Inc., announced that it has received final approval for its Lanreotide Injection, from the...
Cipla to acquire 33 percent stake in Clean Max Auriga Power Ruchika Sharma16 Dec 2021 3:27 PM ISTMumbai: Cipla Limited has announced that the company has acquired up to 33% of partnership interest in Clean Max Auriga Power LLP (Limited Liability...
Cipla to give nebulisers to primary health care centres in India Ruchika Sharma13 Dec 2021 1:31 PM ISTNew Delhi: Homegrown pharma major Cipla Ltd on Friday said it will donate 5,000 nebulisers to primary health care centres in India as part of its...
